z-logo
open-access-imgOpen Access
Proceedings: Regenerative Medicine for Lung Diseases: A CIRM Workshop Report
Author(s) -
Kadyk Lisa C.,
DeWitt Natalie D.,
Gomperts Brigitte
Publication year - 2017
Publication title -
stem cells translational medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.781
H-Index - 71
eISSN - 2157-6580
pISSN - 2157-6564
DOI - 10.1002/sctm.17-0047
Subject(s) - regenerative medicine , stem cell , medicine , lung , intensive care medicine , bioinformatics , pathology , biology , genetics
Summary The mission of the California Institute of Regenerative Medicine (CIRM) is to accelerate treatments to patients with unmet medical needs. In September 2016, CIRM sponsored a workshop held at the University of California, Los Angeles, to discuss regenerative medicine approaches for treatment of lung diseases and to identify the challenges remaining for advancing such treatments to the clinic and market approval. Workshop participants discussed current preclinical and clinical approaches to regenerative medicine in the lung, as well as the biology of lung stem cells and the role of stem cells in the etiology of various lung diseases. The outcome of this effort was the recognition that whereas transient cell delivery approaches are leading the way in the clinic, recent advances in the understanding of lung stem cell biology, in vitro and in vivo disease modeling, gene editing and replacement methods, and cell engraftment approaches raise the prospect of developing cures for some lung diseases in the foreseeable future. In addition, advances in in vitro modeling using lung organoids and “lung on a chip” technology are setting the stage for high quality small molecule drug screening to develop treatments for lung diseases with complex biology. S tem C ells T ranslational M edicine 2017;6:1823–1828

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here